Categories: All postsAnalysts

Cineplex gets price target cut at Echelon Wealth

Ellis Jacob, president and chief executive officer, Cineplex Entertainment.

Ahead of what he expects will be a tough third quarter, Echelon Wealth Partners analyst Rob Goff has cut his price target on Cineplex (Cineplex Stock Quote, Chart, News: TSX:CGX).

In a research update to clients today, Goff maintained his “Buy” rating, but lowered his one-year price target on Cineplex from $56.00 to $50.00, implying a return of 35.9 per cent at the time of publication. The analyst says the company faced some unusual challenges in the quarter.

“Our cautious view towards the box office remains largely unchanged, we do consider Q317 to be an extreme, where the Mayweather/McGregor fight drew tremendous attention, and deterred studios from releasing films around such an event,” he explains. “Looking to the Box Office Mojo tracking of North American box office revenues, July was down 32.8% y/y, followed by August declining 50.0% y/y. September started off slowly, but has raced ahead to a MTD gain of 37.4% y/y.

But Goff cautions against too much optimism.

“Before extrapolating the September trending, we should caution that September 2016 was a tougher month, weighing in (sorry for the second boxing reference) at only 21.3% of the Q316 revenues – down from 27.6% for Q315,” the analyst notes. “This analysis also highlights that September is typically less than a third of the quarter. While investors are likely looking for a below-consensus quarter and increasingly anticipating a negative prequarter analyst dance, we are wary of further pressure ahead of the quarter. We do expect investors to hold on to the view of a stronger Q417, but, nonetheless, we are cautious overthe near term. We note Q417 is expected to record double-digit year-on-year growth, in part due to its measurement against a Q416 where box office revenues declined 6.6% y/y.”

Goff thinks Cineplex will generate EBITDA of $232.0-million on revenue of $1.57-billion in fiscal 2017. He expects those numbers will improve to EBITDA of $258.3-million on a topline of $1.67-billion the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cgx
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

18 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

19 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

19 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

1 day ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago